Metabolomic Signature Between Metabolically Healthy Overweight/Obese and Metabolically Unhealthy Overweight/Obese: A Systematic Review

References

• Flegal KM , Kit BK , Orpana H , Graubard BI . Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA . 2013;309(1):71–82. doi:10.1001/jama.2012.113905 23280227
   PubMed Web of Science ®Google Scholar
• Riaz H , Khan MS , Siddiqi TJ , et al. Association between obesity and cardiovascular outcomes: a systematic review and meta-analysis of mendelian randomization studies. JAMA Network Open . 2018;1(7):e183788. doi:10.1001/jamanetworkopen.2018.3788 30646365
   PubMed Web of Science ®Google Scholar
• Guh DP , Zhang W , Bansback N , Amarsi Z , Birmingham CL , Anis AH . The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health . 2009;9:88.19320986
   PubMed Web of Science ®Google Scholar
• Ahirwar R , Mondal PR . Prevalence of obesity in India: a systematic review. Diabetes Metab Syndr . 2019;13(1):318–321.30641719
   PubMed Web of Science ®Google Scholar
• Primeau V , Coderre L , Karelis AD , et al. Characterizing the profile of obese patients who are metabolically healthy. Int j Obesity . 2011;35(7):971–981.
   PubMed Web of Science ®Google Scholar
• Rey-López JP , de Rezende LF , Pastor-Valero M , Tess BH . The prevalence of metabolically healthy obesity: a systematic review and critical evaluation of the definitions used. Obesity Rev . 2014;15(10):781–790.
   PubMed Web of Science ®Google Scholar
• Phillips CM . Metabolically healthy obesity: definitions, determinants and clinical implications. Rev Endocr Metab Disord . 2013;14(3):219–227.23928851
   PubMed Web of Science ®Google Scholar
• Stefan N , Häring HU , Hu FB , Schulze MB . Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. Lancet Diabetes Endocrinol . 2013;1(2):152–162.24622321
   PubMed Web of Science ®Google Scholar
• Feng T , Vegard M , Strand LB , et al. Metabolically healthy obesity and risk for atrial fibrillation: the HUNT Study. Obesity . 2019;27(2):332–338.30605242
   PubMed Web of Science ®Google Scholar
• Liang P , Xi L , Shi J , et al. Prevalence of polycystic ovary syndrome in Chinese obese women of reproductive age with or without metabolic syndrome. Fertil Steril . 2017;107(4):1048–1054. doi:10.1016/j.fertnstert.2016.12.029 28238496
   PubMed Web of Science ®Google Scholar
• Lotti F , Rastrelli G , Maseroli E , et al. Impact of metabolically healthy obesity in patients with andrological problems. J Sex Med . 2019;16(6):821–832. doi:10.1016/j.jsxm.2019.03.006 30962157
   PubMed Web of Science ®Google Scholar
• Bujak R , Struck-Lewicka W , Markuszewski MJ , Kaliszan R . Metabolomics for laboratory diagnostics. J Pharm Biomed Anal . 2015;113:108–120. doi:10.1016/j.jpba.2014.12.017 25577715
   PubMed Web of Science ®Google Scholar
• Libert DM , Nowacki AS , Natowicz MR . Metabolomic analysis of obesity, metabolic syndrome, and type 2 diabetes: amino acid and acylcarnitine levels change along a spectrum of metabolic wellness. PeerJ . 2018;6:e5410. doi:10.7717/peerj.5410 30186675
   PubMed Web of Science ®Google Scholar
• Rangel-Huerta OD , Pastor-Villaescusa B , Gil A . Are we close to defining a metabolomic signature of human obesity? A systematic review of metabolomics studies. Metabolomics . 2019;15(6):93. doi:10.1007/s11306-019-1553-y 31197497
   PubMed Web of Science ®Google Scholar
• Guasch-Ferré M , Hruby A , Toledo E , et al. Metabolomics in prediabetes and diabetes: a systematic review and meta-analysis. Diabetes Care . 2016;39(5):833–846. doi:10.2337/dc15-2251 27208380
   PubMed Web of Science ®Google Scholar
• Zhao X , Gang X , Liu Y , Sun C , Han Q , Wang G . Using metabolomic profiles as biomarkers for insulin resistance in childhood obesity: a systematic review. J Diabetes Res . 2016;2016:8160545. doi:10.1155/2016/8160545 27517054
   PubMed Web of Science ®Google Scholar
• Zhang Y , Zhang S , Wang G . Metabolomic biomarkers in diabetic kidney diseases—A systematic review. J Diabetes Complications . 2015;29(8):1345–1351. doi:10.1016/j.jdiacomp.2015.06.016 26253264
   PubMed Web of Science ®Google Scholar
• Lumbreras B , Porta M , Márquez S , Pollán M , Parker LA , Hernández-Aguado I . QUADOMICS: an adaptation of the Quality Assessment of Diagnostic Accuracy Assessment (QUADAS) for the evaluation of the methodological quality of studies on the diagnostic accuracy of ‘-omics’-based technologies. Clin Biochem . 2008;41(16–17):1316–1325. doi:10.1016/j.clinbiochem.2008.06.018 18652812
   PubMed Web of Science ®Google Scholar
• Whiting P , Rutjes AW , Reitsma JB , Bossuyt PM , Kleijnen J . The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol . 2003;3(1):25. doi:10.1186/1471-2288-3-25 14606960
   PubMedGoogle Scholar
• Telle-Hansen VH , Christensen JJ , Formo GA , Holven KB , Ulven SM . A comprehensive metabolic profiling of the metabolically healthy obesity phenotype. Lipids Health Dis . 2020;19(1):90. doi:10.1186/s12944-020-01273-z 32386512
   PubMed Web of Science ®Google Scholar
• Kim M , Yoo HJ , Ko J , Lee JH . Metabolically unhealthy overweight individuals have high lysophosphatide levels, phospholipase activity, and oxidative stress. Clin Nutrition . 2020;39(4):1137–1145. doi:10.1016/j.clnu.2019.04.025
   Web of Science ®Google Scholar
• Chashmniam S , Madani NH , Ghoochani BFNM , Safari-Alighiarloo N , Khamseh ME . The metabolome profiling of obese and non-obese individuals: metabolically healthy obese and unhealthy non-obese paradox. Iran J Basic Med Sci . 2020;23(2):186–194. doi:10.22038/IJBMS.2019.37885.9004 32405361
   PubMed Web of Science ®Google Scholar
• Ojwang AA , Smuts CM , Zec M , Wentzel-Viljoen E , Kruger IM , Kruger HS . Comparison of dietary and plasma phospholipid fatty acids between normal weight and overweight black South Africans according to metabolic health: the PURE study. Prostaglandins Leukot Essent Fatty Acids . 2019;102039.31780327
   PubMed Web of Science ®Google Scholar
• Candi E , Tesauro M , Cardillo C , et al. Metabolic profiling of visceral adipose tissue from obese subjects with or without metabolic syndrome. Biochem J . 2018;475(5):1019–1035. doi:10.1042/BCJ20170604 29437994
   PubMed Web of Science ®Google Scholar
• Bervoets L , Massa G , Guedens W , Reekmans G , Noben J-P , Adriaensens P . Identification of metabolic phenotypes in childhood obesity by 1 H NMR metabolomics of blood plasma. Fut Sci OA . 2018;4(6):6. doi:10.4155/fsoa-2017-0146
   Web of Science ®Google Scholar
• Bagheri M , Farzadfar F , Qi L , et al. Obesity-Related Metabolomic Profiles and Discrimination of Metabolically Unhealthy Obesity. J Proteome Res . 2018;17(4):1452–1462. doi:10.1021/acs.jproteome.7b00802 29493238
   PubMed Web of Science ®Google Scholar
• Zhong F , Xu M , Bruno RS , Ballard KD , Zhu J . Targeted high performance liquid chromatography tandem mass spectrometry-based metabolomics differentiates metabolic syndrome from obesity. Exp Biol Med . 2015;29(8):773–780. doi:10.1177/1535370217694098
   Web of Science ®Google Scholar
• Gao X , Zhang W , Wang Y , et al. Serum metabolic biomarkers distinguish metabolically healthy peripherally obese from unhealthy centrally obese individuals. Nutr Metab . 2016;13:1. doi:10.1186/s12986-016-0095-9
   Google Scholar
• Allam-Ndoul B , Guénard F , Garneau V , et al. Association between Metabolite profiles, metabolic syndrome and obesity status. Nutrients . 2016;8(6):6. doi:10.3390/nu8060324
   Web of Science ®Google Scholar
• Ni Y , Zhao L , Yu H , et al. Circulating unsaturated fatty acids delineate the metabolic status of obese individuals. EBioMed . 2015;2(10):1513–1522.
   Web of Science ®Google Scholar
• Chen HH , Tseng YJ , Wang SY , et al. The metabolome profiling and pathway analysis in metabolic healthy and abnormal obesity. Int j Obesity . 2015;39(8):1241–1248.
   Web of Science ®Google Scholar
• Perreault M , Zulyniak MA , Badoud F , et al. A distinct fatty acid profile underlies the reduced inflammatory state of metabolically healthy obese individuals. PLoS One . 2014;9(2):e88539.24520395
   PubMed Web of Science ®Google Scholar
• Cheng S , Wiklund PK , Pekkala S , et al. Serum metabolic profiles in overweight and obese women with and without metabolic syndrome. Diabetol Metab Syndr . 2014;6:1.24383616
   PubMed Web of Science ®Google Scholar
• Böhm A , Halama A , Meile T , et al. Metabolic signatures of cultured human adipocytes from metabolically healthy versus unhealthy obese individuals. PLoS One . 2014;9:4.
   Web of Science ®Google Scholar
• Badoud F , Lam KP , DiBattista A , et al. Serum and adipose tissue amino acid homeostasis in the metabolically healthy obese. J Proteome Res . 2014;13(7):3455–3466.24933025
   PubMed Web of Science ®Google Scholar
• Batch BC , Shah SH , Newgard CB , et al. Branched chain amino acids are novel biomarkers for discrimination of metabolic wellness. Metabolism . 2013;62(7):961–969.23375209
   PubMed Web of Science ®Google Scholar
• Rousseau M , Guénard F , Garneau V , et al. Associations between dietary protein sources, plasma BCAA and short-chain acylcarnitine levels in adults. Nutrients . 2019;11:1.
   Web of Science ®Google Scholar
• Haufe S , Witt H , Engeli S , et al. Branched-chain and aromatic amino acids, insulin resistance and liver specific ectopic fat storage in overweight to obese subjects. Nutr Metabol Cardiovasc Dis . 2016;26(7):637–642.
   Web of Science ®Google Scholar
• Yoon MS . The emerging role of branched-chain amino acids in insulin resistance and metabolism. Nutrients . 2016;8:7.
   Web of Science ®Google Scholar
• Lynch CJ , Adams SH . Branched-chain amino acids in metabolic signalling and insulin resistance. Nat Rev Endocrinol . 2014;10(12):723–736.25287287
   PubMed Web of Science ®Google Scholar
• Krebs M , Brehm A , Krssak M , et al. Direct and indirect effects of amino acids on hepatic glucose metabolism in humans. Diabetologia . 2003;46(7):917–925.12819901
   PubMed Web of Science ®Google Scholar
• Wang TJ , Larson MG , Vasan RS , et al. Metabolite profiles and the risk of developing diabetes. Nat Med . 2011;17(4):448–453.21423183
   PubMed Web of Science ®Google Scholar
• Lotta LA , Scott RA , Sharp SJ , et al. Genetic predisposition to an impaired metabolism of the branched-chain amino acids and risk of type 2 diabetes: a mendelian randomisation analysis. PLoS Med . 2016;13(11):e1002179.27898682
   PubMed Web of Science ®Google Scholar
• Ruiz-Canela M , Guasch-Ferré M , Toledo E , et al. Plasma branched chain/aromatic amino acids, enriched Mediterranean diet and risk of type 2 diabetes: case-cohort study within the PREDIMED Trial. Diabetologia . 2018;61(7):1560–1571.29663011
   PubMed Web of Science ®Google Scholar
• Houttu N , Mokkala K , Laitinen K . Overweight and obesity status in pregnant women are related to intestinal microbiota and serum metabolic and inflammatory profiles. Clin nutr . 2018;37(6 Pt A):1955–1966.29338886
   PubMed Web of Science ®Google Scholar
• Li J , Cao YF , Sun XY , et al. Plasma tyrosine and its interaction with low high-density lipoprotein cholesterol and the risk of type 2 diabetes mellitus in Chinese. J Diabetes Investig . 2019;10(2):491–498.
   Web of Science ®Google Scholar
• Gaggini M , Carli F , Rosso C , et al. Altered amino acid concentrations in NAFLD: impact of obesity and insulin resistance. Hepatology . 2018;67(1):145–158.28802074
   PubMed Web of Science ®Google Scholar
• Cheng S , Rhee EP , Larson MG , et al. Metabolite profiling identifies pathways associated with metabolic risk in humans. Circulation . 2012;125(18):2222–2231.22496159
   PubMed Web of Science ®Google Scholar
• Müller WA , Faloona GR , Unger RH . The effect of alanine on glucagon secretion. J Clin Invest . 1971;50(10):2215–2218.5116210
   PubMed Web of Science ®Google Scholar
• Wewer Albrechtsen NJ , Færch K , Jensen TM , et al. Evidence of a liver-alpha cell axis in humans: hepatic insulin resistance attenuates relationship between fasting plasma glucagon and glucagonotropic amino acids. Diabetologia . 2018;61(3):671–680.29305624
   PubMed Web of Science ®Google Scholar
• Adams SH . Emerging perspectives on essential amino acid metabolism in obesity and the insulin-resistant state. Adv Nutrition . 2011;2(6):445–456.
   PubMed Web of Science ®Google Scholar
• Irving BA , Carter RE , Soop M , et al. Effect of insulin sensitizer therapy on amino acids and their metabolites. Metabolism . 2015;64(6):720–728.25733201
   PubMed Web of Science ®Google Scholar
• Liu JJ , Movassat J , Portha B . Emerging role for kynurenines in metabolic pathologies. Curr Opin Clin Nutr Metab Care . 2019;22(1):82–90.30407222
   PubMed Web of Science ®Google Scholar
• Rojas DR , Kuner R , Agarwal N . Metabolomic signature of type 1 diabetes-induced sensory loss and nerve damage in diabetic neuropathy. J Mol Med . 2019;97(6):845–854.30949723
   PubMed Web of Science ®Google Scholar
• Korbecki J , Bajdak-Rusinek K . The effect of palmitic acid on inflammatory response in macrophages: an overview of molecular mechanisms. Inflammation Res . 2019;68(11):915–932.
   PubMed Web of Science ®Google Scholar
• Sethom MM , Fares S , Feki M , et al. Plasma fatty acids profile and estimated elongase and desaturases activities in Tunisian patients with the metabolic syndrome. Prostaglandins Leukot Essent Fatty Acids . 2011;85(3–4):137–141.21782403
   PubMed Web of Science ®Google Scholar
• Fatima S , Hu X , Gong RH , et al. Palmitic acid is an intracellular signaling molecule involved in disease development. Cell Mol Life Sci . 2019;76(13):2547–2557.30968170
   PubMed Web of Science ®Google Scholar
• Zhao L , Ni Y , Yu H , et al. Serum stearic acid/palmitic acid ratio as a potential predictor of diabetes remission after Roux-en-Y gastric bypass in obesity. FASEB J . 2017;31(4):1449–1460.28007782
   PubMed Web of Science ®Google Scholar
• Brown TJ , Brainard J , Song F , Wang X , Abdelhamid A , Hooper L . Omega-3, omega-6, and total dietary polyunsaturated fat for prevention and treatment of type 2 diabetes mellitus: systematic review and meta-analysis of randomised controlled trials. BMJ . 2019;366:l4697.31434641
   PubMed Web of Science ®Google Scholar
• Würtz P , Havulinna AS , Soininen P , et al. Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohorts. Circulation . 2015;131(9):774–785.25573147
   PubMed Web of Science ®Google Scholar
• Zong G , Ye X , Sun L , et al. Associations of erythrocyte palmitoleic acid with adipokines, inflammatory markers, and the metabolic syndrome in middle-aged and older Chinese. Am J Clin Nutr . 2012;96(5):970–976.23015321
   PubMed Web of Science ®Google Scholar
• Mayneris-Perxachs J , Guerendiain M , Castellote AI , et al. Plasma fatty acid composition, estimated desaturase activities, and their relation with the metabolic syndrome in a population at high risk of cardiovascular disease. Clin nutr . 2014;33(1):90–97.23591154
   PubMed Web of Science ®Google Scholar
• Malodobra-Mazur M , Cierzniak A , Dobosz T . Oleic acid influences the adipogenesis of 3T3-L1 cells via DNA Methylation and may predispose to obesity and obesity-related disorders. Lipids Health Dis . 2019;18(1):230.31883537
   PubMed Web of Science ®Google Scholar
• Guo XF , Li X , Shi M , Li D . n-3 polyunsaturated fatty acids and metabolic syndrome risk: a meta-analysis. Nutrients . 2017;9:7.
   Web of Science ®Google Scholar
• Rasic-Milutinovic Z , Perunicic G , Pljesa S , et al. Effects of N-3 PUFAs supplementation on insulin resistance and inflammatory biomarkers in hemodialysis patients. Ren Fail . 2007;29(3):321–329.17497447
   PubMed Web of Science ®Google Scholar
• Tavazzi L , Maggioni AP , Marchioli R , et al. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet . 2008;372(9645):1223–1230.18757090
   PubMed Web of Science ®Google Scholar
• Siscovick DS , Barringer TA , Fretts AM , et al. Omega-3 polyunsaturated fatty acid (fish oil) supplementation and the prevention of clinical cardiovascular disease: a science advisory from the american heart association. Circulation . 2017;135(15):e867–e884.28289069
   PubMed Web of Science ®Google Scholar
• Newgard CB , An J , Bain JR , et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab . 2009;9(4):311–326.19356713
   PubMed Web of Science ®Google Scholar
• Mai M , Tönjes A , Kovacs P , Stumvoll M , Fiedler GM , Leichtle AB . Serum levels of acylcarnitines are altered in prediabetic conditions. PLoS One . 2013;8(12):e82459.24358186
   PubMed Web of Science ®Google Scholar
• Aichler M , Borgmann D , Krumsiek J , et al. N-acyl taurines and acylcarnitines cause an imbalance in insulin synthesis and secretion provoking β cell dysfunction in type 2 diabetes. Cell Metab . 2017;25(6):1334–1347.e1334.28591636
   PubMed Web of Science ®Google Scholar
• Koves TR , Ussher JR , Noland RC , et al. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab . 2008;7(1):45–56.18177724
   PubMed Web of Science ®Google Scholar
• Rauschert S , Uhl O , Koletzko B , Hellmuth C . Metabolomic biomarkers for obesity in humans: a short review. Ann Nutr Metab . 2014;64(3–4):314–324.25300275
   PubMed Web of Science ®Google Scholar
• Caleyachetty R , Thomas GN , Toulis KA , et al. Metabolically healthy obese and incident cardiovascular disease events among 3.5 million men and women. J Am Coll Cardiol . 2017;70(12):1429–1437.28911506
   PubMed Web of Science ®Google Scholar
• Bell JA , Kivimaki M , Hamer M . Metabolically healthy obesity and risk of incident type 2 diabetes: a meta-analysis of prospective cohort studies. Obesity Rev . 2014;15(6):504–515.
   PubMed Web of Science ®Google Scholar
• Lee SK , Kim SH , Cho GY , et al. Obesity phenotype and incident hypertension: a prospective community-based cohort study. J Hypertens . 2013;31(1):145–151.23079679
   PubMed Web of Science ®Google Scholar
• Ruiz JR , Ortega FB , Labayen I . A weight loss diet intervention has a similar beneficial effect on both metabolically abnormal obese and metabolically healthy but obese premenopausal women. Ann Nutr Metab . 2013;62(3):223–230.23571719
   PubMed Web of Science ®Google Scholar